Centaurus Financial, Inc. Pfizer Inc Transaction History

Centaurus Financial, Inc.

$1.44 Billion
Q3 2024

A detailed history of Centaurus Financial, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Centaurus Financial, Inc. holds 64,543 shares of PFE stock, worth $1.73 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

64,543

Previous 62,413 3.41%

Holding current value

$1.73 Million

Previous $1.75 Million 6.93%

% of portfolio

0.13%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $59,001 - $66,860	2,130 Added 3.41%	64,543 $1.87 Million
Q2 2024 Sep 20, 2024	SELL	$25.26 - $29.6 $30,185 - $35,372	-1,195 Reduced 1.88%	62,413 $1.75 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $93,954 - $107,890	-3,629 Reduced 5.4%	63,608 $1.77 Million
Q4 2023 Feb 26, 2024	BUY	$26.13 - $33.94 $50,012 - $64,961	1,914 Added 2.93%	67,237 $1.94 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $38,411 - $44,899	-1,197 Reduced 1.8%	65,323 $2.17 Million
Q2 2023 Aug 15, 2023	SELL	$36.12 - $41.79 $984,775 - $1.14 Million	-27,264 Reduced 29.07%	66,520 $2.44 Million
Q1 2023 May 17, 2023	SELL	$39.39 - $51.28 $154,014 - $200,504	-3,910 Reduced 4.0%	93,784 $3.83 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $194,012 - $253,261	-4,647 Reduced 4.54%	97,694 $5.01 Million
Q3 2022 Dec 05, 2022	SELL	$43.76 - $53.42 $249,519 - $304,600	-5,702 Reduced 5.28%	102,341 $4.48 Million
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $324,546 - $384,810	6,975 Added 6.9%	108,043 $5.67 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $832,421 - $1.03 Million	18,195 Added 21.96%	101,068 $5.23 Million
Q4 2021 Feb 01, 2022	BUY	$41.32 - $61.25 $38,097 - $56,472	922 Added 1.13%	82,873 $4.89 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $123,127 - $158,167	-3,137 Reduced 3.69%	81,951 $3.53 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $958,940 - $1.09 Million	26,704 Added 45.74%	85,088 $3.33 Million
Q1 2021 Apr 30, 2021	BUY	$33.49 - $37.77 $195,615 - $220,614	5,841 Added 11.12%	58,384 $2.12 Million
Q4 2020 Jan 25, 2021	BUY	$33.47 - $42.56 $412,417 - $524,424	12,322 Added 30.64%	52,543 $1.93 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $319,151 - $374,437	-10,052 Reduced 19.99%	40,221 $1.48 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $43,884 - $53,238	-1,457 Reduced 2.82%	50,273 $1.64 Million
Q1 2020 Apr 21, 2020	BUY	$27.03 - $38.62 $141,258 - $201,828	5,226 Added 11.24%	51,730 $1.69 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $279,754 - $317,485	8,498 Added 22.36%	46,504 $1.82 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $11,826 - $15,335	-364 Reduced 0.95%	38,006 $1.37 Million
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $1.36 Million - $1.53 Million	36,767 Added 2293.64%	38,370 $1.66 Million
Q1 2019 Jul 01, 2019	SELL	$37.5 - $41.2 $1.36 Million - $1.49 Million	-36,138 Reduced 95.75%	1,603 $37.7 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $1.36 Million - $1.49 Million	36,190 Added 2333.33%	37,741 $1.6 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $58,474 - $66,667	1,520 Added 4903.23%	1,551 $36,000
Q3 2018 Nov 05, 2018	SELL	$34.47 - $41.81 $2.34 Million - $2.83 Million	-67,765 Reduced 99.95%	31 $1.36 Million
Q2 2018 Aug 15, 2018	BUY	$32.98 - $35.16 $2 Million - $2.13 Million	60,603 Added 842.53%	67,796 $2.46 Million
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $17,805 - $20,657	558 Added 8.41%	7,193 $255,000
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $220,680 - $234,149	6,635	6,635 $240,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.

Account

Centaurus Financial, Inc. Pfizer Inc Transaction History